Shanghai VKEY Biotechnologies Co.,Ltd.
Shanghai VKEY Biotechnologies Co.,Ltd.
Email Us

VKEY-BIO Participated in the 6th China Biomedicine Innovation Cooperation Conference

On August 4, 2022, the 6th China Biopharmaceutical Innovation Cooperation Conference and the 2022 China Biopharmaceutical Industry Value List Award Ceremony were held in Suzhou. This conference focused on cutting-edge technology information, interpretation of the latest industrial policies, linking the multi-platform of industry, university and research, opening up the upstream and downstream industrial chain around multiple channels, accelerating the industrialization of biomedicine, and comprehensively empowering industrial development, proposing new ideas, methods and explorations. It has established a high-level communication platform under the new era background for the continuous promotion of high-quality development of the domestic biopharmaceutical industry and the collaborative sharing of industry ecology. VKEY-BIO attended the conference as a sponsor of this session.


VKEY-BIO Participated in the 6th China Biomedicine Innovation Cooperation Conference


At the exhibition site, VKEY-BIO booth showcased products such as reporter gene detection kits, small animal in vivo imaging, and technical service solutions. The exhibition area was bustling with activity and a lively atmosphere, attracting numerous visitors to stop and view the products. The staff provided enthusiastic service and professional knowledge, engaging in detailed exchanges with many interested clients, which helped everyone gain a clearer understanding of VKEY-BIO products and the company's strength.


About VKEY-BIO

VKEY-BIO, founded in 2019, is a biotechnology company dedicated to the research and production of reagents for life sciences. Recognized as a "High-Tech Enterprise," an "Innovative SME," and a "Technology-Based SME" in China, our focus is on providing high-quality reagents. Our mission is to contribute to the reduction of drug discovery costs by offering comprehensive and customized solutions for your research. 


Our products primarily based on Luminescent and TR-FRET technology platforms, designed for drugs screening and validation purposes. Notably, our independently developed KeyTec® TR-FRET technology employs the stable energy donor (Solar Eu/Tb) and the stable energy acceptor (LA/HX) in a time-resolved fluorescence resonance energy transfer system. TR-FRET is known for its ease of use, homogeneity (no wash), low background, wide range and robustness. Furthermore, our independently developed KeyTec® Luminescent is known for its high sensitivity and robust luminescence. We eagerly anticipate the opportunity to collaborate with you, fostering advancements in life science research together.

NEXT: No information